Cargando…

Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia

Chronic kidney disease (CKD) represents a serious concern for the Mexican population since the main predisposing diseases (diabetes, hypertension, etc.) have a high prevalence in the country. The development of frequent comorbidities during CKD such as anemia, metabolic disorders, and hyperphosphate...

Descripción completa

Detalles Bibliográficos
Autores principales: Palafox-Serdán, Frida, Luna-Montiel, Olinto A., Pablo-Franco, Sebastián E., Guillen-Tejada, Daniela L., Carreño-Vázquez, Sandra D., Silva Pereira, Taísa S., Islas Romero, Laura M., Villaseñor López, Karen, Ortega-Régules, Ana E., Jiménez-Garduño, Aura M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693767/
https://www.ncbi.nlm.nih.gov/pubmed/33121062
http://dx.doi.org/10.3390/nu12113289
_version_ 1783614821302796288
author Palafox-Serdán, Frida
Luna-Montiel, Olinto A.
Pablo-Franco, Sebastián E.
Guillen-Tejada, Daniela L.
Carreño-Vázquez, Sandra D.
Silva Pereira, Taísa S.
Islas Romero, Laura M.
Villaseñor López, Karen
Ortega-Régules, Ana E.
Jiménez-Garduño, Aura M.
author_facet Palafox-Serdán, Frida
Luna-Montiel, Olinto A.
Pablo-Franco, Sebastián E.
Guillen-Tejada, Daniela L.
Carreño-Vázquez, Sandra D.
Silva Pereira, Taísa S.
Islas Romero, Laura M.
Villaseñor López, Karen
Ortega-Régules, Ana E.
Jiménez-Garduño, Aura M.
author_sort Palafox-Serdán, Frida
collection PubMed
description Chronic kidney disease (CKD) represents a serious concern for the Mexican population since the main predisposing diseases (diabetes, hypertension, etc.) have a high prevalence in the country. The development of frequent comorbidities during CKD such as anemia, metabolic disorders, and hyperphosphatemia increases the costs, symptoms, and death risks of the patients. Hyperphosphatemia is likely the only CKD comorbidity in which pharmaceutical options are restricted to phosphate binders and where nutritional management seems to play an important role for the improvement of biochemical and clinical parameters. Nutritional interventions aiming to control serum phosphate levels need to be based on food tables, which should be specifically elaborated for the cultural context of each population. Until now, there are no available food charts compiling a high amount of Mexican foods and describing phosphorus content as well as the phosphate to protein ratio for nutritional management of hyperphosphatemia in CKD. In this work, we elaborate a highly complete food chart as a reference for Mexican clinicians and include charts of additives and drug phosphate contents to consider extra sources of inorganic phosphate intake. We aim to provide an easy guideline to contribute to the implementation of more nutritional interventions focusing on this population in the country.
format Online
Article
Text
id pubmed-7693767
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76937672020-11-28 Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia Palafox-Serdán, Frida Luna-Montiel, Olinto A. Pablo-Franco, Sebastián E. Guillen-Tejada, Daniela L. Carreño-Vázquez, Sandra D. Silva Pereira, Taísa S. Islas Romero, Laura M. Villaseñor López, Karen Ortega-Régules, Ana E. Jiménez-Garduño, Aura M. Nutrients Article Chronic kidney disease (CKD) represents a serious concern for the Mexican population since the main predisposing diseases (diabetes, hypertension, etc.) have a high prevalence in the country. The development of frequent comorbidities during CKD such as anemia, metabolic disorders, and hyperphosphatemia increases the costs, symptoms, and death risks of the patients. Hyperphosphatemia is likely the only CKD comorbidity in which pharmaceutical options are restricted to phosphate binders and where nutritional management seems to play an important role for the improvement of biochemical and clinical parameters. Nutritional interventions aiming to control serum phosphate levels need to be based on food tables, which should be specifically elaborated for the cultural context of each population. Until now, there are no available food charts compiling a high amount of Mexican foods and describing phosphorus content as well as the phosphate to protein ratio for nutritional management of hyperphosphatemia in CKD. In this work, we elaborate a highly complete food chart as a reference for Mexican clinicians and include charts of additives and drug phosphate contents to consider extra sources of inorganic phosphate intake. We aim to provide an easy guideline to contribute to the implementation of more nutritional interventions focusing on this population in the country. MDPI 2020-10-27 /pmc/articles/PMC7693767/ /pubmed/33121062 http://dx.doi.org/10.3390/nu12113289 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Palafox-Serdán, Frida
Luna-Montiel, Olinto A.
Pablo-Franco, Sebastián E.
Guillen-Tejada, Daniela L.
Carreño-Vázquez, Sandra D.
Silva Pereira, Taísa S.
Islas Romero, Laura M.
Villaseñor López, Karen
Ortega-Régules, Ana E.
Jiménez-Garduño, Aura M.
Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia
title Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia
title_full Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia
title_fullStr Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia
title_full_unstemmed Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia
title_short Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia
title_sort nutritional guideline for the management of mexican patients with ckd and hyperphosphatemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693767/
https://www.ncbi.nlm.nih.gov/pubmed/33121062
http://dx.doi.org/10.3390/nu12113289
work_keys_str_mv AT palafoxserdanfrida nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia
AT lunamontielolintoa nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia
AT pablofrancosebastiane nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia
AT guillentejadadanielal nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia
AT carrenovazquezsandrad nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia
AT silvapereirataisas nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia
AT islasromerolauram nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia
AT villasenorlopezkaren nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia
AT ortegaregulesanae nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia
AT jimenezgardunoauram nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia